All
3 Things You Should Know About HS Pathology and Management
Earn CME credit and learn how to optimize a multimodal treatment approach for hidradenitis suppurativa.
Discovering Dermatology Times: April 2024
Learn more about the in-depth topics covered in the April 2024 print issue of Dermatology Times.
A Simple Financing Solution for Patient Health, Wellness, and Beauty
A Simple Financing Solution for Medical Aesthetic Practices
Rosacea Awareness Month Recap
Review Dermatology Times' coverage of Rosacea Awareness Month.
Dermatology Times April 2024 Recap
Dermatology Times is looking back on the top stories in dermatology from the month of April.
Eli Lilly Resubmits BLA for Lebrikizumab for the Treatment of Moderate to Severe AD
A decision from the FDA is expected in the second half of 2024.
Interview Intersection: Expert Interviews From April 2024
Dermatology Times is recapping our top expert interviews from the month of April.
Anna López-Ferrer, MD, PhD, and Volker Koscielny, MD, MBA, Share Highlights From Almirall’s 15th Skin Academy
López-Ferrer discussed how to achieve well-being for patients with psoriasis and Koscielny discussed the unique topics of the Skin Academy.
Versus Red Light PDT, Patients With Actinic Keratosis Prefer Simulated Daylight PDT
A study revealed that patients with actinic keratosis reported feeling more pain during red light PDT compared to simulated daylight PDT.
Cosmetic, Psychological Impact of Punch Biopsy in Patients With Tattooed Skin is Minimal
A study found that in addition, recovery time was both quick and yielded minimal symptoms.
FDA Accepts Dermavant’s sNDA for Tapinarof Cream 1% for Adults and Children With AD
The FDA’s PDUFA date is expected in quarter 4 of 2024.
QUIZ: Test Your Knowledge of Rosacea Research and Innovations
Click here to read more and answer our quiz questions in recognition of Rosacea Awareness Month.
Derm In The News: April 21-27
Keep up with the latest headlines in dermatology from the past week, including the appointment of All Detergent's first chief dermatology advisor, Incyte's acquisition of Escient Pharmaceuticals, and more.
The Weekly Roundup: April 22-26
ICYMI, this week we had news about a study of upadacitinib versus dupilumab in atopic dermatitis, the European Union's approval of bimekizumab for HS, and more.
Clinician and Patient Perspective: Tapinarof Cream for Plaque Psoriasis
Mona Shahriari, MD, and a plaque psoriasis patient provide insights into the mechanism of action and benefits of tapinarof cream 1% as a nonsteroidal topical.
Optical Coherence Tomography in Preoperative Mapping of BCC: A Novel Approach to Optimizing Mohs Micrographic Surgery
Study findings suggest OCT's effectiveness in accurately diagnosing and mapping BCC, with a high predictive capability for Mohs surgery requirements.
Colorimetric Scale Offers Practical Classification in Clinical Assessment of Skin of Color
Skin cancer risk classification lacks reliability for darker skin tones and fails in evaluating cutaneous medical conditions or cosmetic interventions, according to creators of the scale.
QUIZ RECAP: Test Your Knowledge of Rosacea Treatment Modalities and the Therapeutic Landscape
Earlier this week, we shared our third Rosacea Awareness Month quiz. Review the answers and your responses below.
Addressing Disparities in Skin-Aging Prevention Among Women of Color
A recent survey covered topics including skin-aging prevention, care-seeking behavior, trust in professionals, and more.
Biologic Therapy Linked to Increased Density of Demodex Mites and Prevalence of Demodicosis in Patients With Psoriasis vs Controls
A cross-sectional study revealed an increase and heightened prevalence of Demodex and demodicosis in individuals with psoriasis receiving biologic therapy.
Upadacitinib Outperforms Dupilumab in Primary and Secondary End Points in Head-to-Head AD Study
In LEVEL-UP, upadacitinib demonstrated superiority over dupilumab in achieving EASI-90 and little to no itch at week 16.
Patients With Hidradenitis Suppurativa Have Increased Odds of Respiratory Disease, According to Study Findings
Researchers conducted a population-based study examining a sample of patients with HS during hospital admissions.
Seemal Desai, MD, Responds to Study Suggesting Melanoma is Overdiagnosed in White Patients
Desai emphasized that most dermatologists would rather biopsy a potential melanoma than miss one that could become deadly.
Federal Trade Commission Votes to Ban Noncompete Clauses Between Employers and Workers
In online discussion April 23, commissioners cited health care specifically among their reasons for supporting the ban.
Facial Skin Cancer Surgery Yields Low and Improved Scores For Perceived Stigmatization, Body Image Concerns, and Psychosocial Distress
A review found that Mohs micrographic surgery and conventional excision yielded comparable patient reported outcomes.
US Central and European Commands Should Revisit Disallowance of Systemic Treatments for Deployed Individuals With Psoriasis, Eczema, Paper Argues
At present, deployed members of the military are not permitted to be receiving therapy with systemic therapies such as immunomodulators and biologics.
Ruxolitinib, Educational Initiatives for Managed Care Professionals Play Crucial Role in Optimizing Care in Atopic Dermatitis
Posters from the Academy of Managed Care Pharmacy annual meeting featured studies on atopic dermatitis.
ASLAN Announces Positive Phase 2 Results of Eblasakimab in Dupilumab-Treated Patients With AD
Sixty percent of dupilumab-treated patients with AD treated with 400mg of eblasakimab weekly achieved EASI-90 after 16 weeks.
Jessner’s Lymphocytic Infiltration of the Skin Mimicking Rosacea: A Rare Case Presentation
Chinese clinical researchers recently presented a unique case of JLIS manifesting as erythematous papules and infiltrative plaques on the nose and upper jaw, resembling rosacea.
